Arrowhead (ARWR) is down -11.5%, or -$1.92 to $14.84.
Easter Sale - 70% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARWR:
- Arrowhead falls -8.9%
- Cautious Hold Rating on Arrowhead Pharmaceuticals Amid Uncertainty in Sarepta Partnership
- Arrowhead Pharmaceuticals Advances Phase 3 Study of Zodasiran for Cholesterol Management
- Arrowhead Pharmaceuticals Advances Phase 3 Study on Plozasiran for Hypertriglyceridemia
- Arrowhead doses first patient in YOSEMITE trial